Predicting jaundice return after light therapy in newborns
Part of Genetic & congenital clinical trials.
This study looks at newborn babies treated with light therapy for jaundice to find out who might need extra monitoring after treatment stops. It aims to help doctors predict if jaundice will come back within 48 hours.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby was treated with light therapy for jaundice in the NICU
- Your baby was born at 35 weeks or later
- Doctors measured your baby's bilirubin levels before, during, and after light therapy
- Doctors checked bilirubin again within 48 hours after stopping light therapy
- You or the legal guardian signed a consent form if required
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether holding your baby skin-to-skin (kangaroo care) during light therapy for jaundice can help reduce their pain and discomfort. It aims to see if this simple comfort measure is beneficial.
This trial tests different ways to give light therapy to newborns with jaundice. It compares different approaches to see which is best, and may help parents understand the most effective treatment for their baby.
This trial tests a scoring tool called BIND to see how well it predicts which newborns with severe jaundice need intensive treatment. If you have a baby under 28 days old with severe jaundice that might need a blood transfusion, this study could apply to them.
This study looks for a safe threshold to stop the “light therapy” (phototherapy) in newborns who have jaundice caused by blood cell breakdown (hemolytic disease). It may help some babies avoid unnecessary extra days of treatment while still staying safe.
This trial compares different blood-bilirubin (jaundice) thresholds for treating very premature babies (born before 30 weeks) in the NICU. It aims to find the safest way to manage jaundice to prevent complications.
This study checks whether a device that reads bilirubin through the skin can be used to guide treatment with newborn phototherapy (special light). It may help babies with jaundice get the right monitoring and light treatment safely.
Hear when a new Neonatal Hyperbilirubinemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.